UNSPSC 85282801: Diagnosis of alzheimer disease with early onset

This classification denotes the group of activities that yields a diagnosis of Alzheimer disease with early onset. Alzheimer disease with early onset is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code G30. 0

UNSPSC 85282801 Diagnosis of alzheimer disease with early onset (Commodity) shows minimal alignment with recent state and local procurement activity. The three most recent opportunities tagged under this code—a diagnostic imaging PACS system at San Mateo Medical Center, special education contracted services at Birdville Independent School District in Texas, and temporary health professional staffing at Santa Clara County Health System—do not substantively address Alzheimer's disease diagnosis, early-onset screening, or related clinical services. The San Mateo opportunity centers on enterprise imaging infrastructure (radiology, cardiology, dental, and mammography), the school district solicitation covers behavioral health and educational services (speech therapy, occupational therapy, psychology), and Santa Clara's solicitation seeks temporary staffing across ancillary clinical roles (audiology, respiratory care, sterile processing) with no mention of neurological or dementia-specific diagnosis.

This code presents little relevant recent activity for business development targeting state and local Alzheimer's disease diagnostic services. The mismatch between the code's nominal scope and the work actually being solicited suggests either tagging error by the issuing bodies or minimal procurement volume for early-onset Alzheimer's diagnosis under this specific UNSPSC classification. Firms pursuing contracts in neurology, cognitive assessment, or dementia screening should monitor whether state health systems, county departments of aging, or independent school districts issue future RFPs or RFQs for neuropsychological testing, advanced imaging (PET, amyloid imaging), biomarker testing, or diagnostic consultation services—but no such opportunities are present in the current pipeline under this code.